Publications 2025

Wik JA, Stromsnes K, Skålhegg BS (2025)
Using Seahorse Technology as an Efficient Way of Verifying T Cell Stimulation
2904, 219-242
DOI 10.1007/978-1-0716-4414-0_16, PubMed 40220237

Publications 2024

Wilhelmsen I, Combriat T, Dalmao-Fernandez A, Stokowiec J, Wang C, Olsen PA, Wik JA, Boichuk Y, Aizenshtadt A, Krauss S (2024)
The effects of TGF-β-induced activation and starvation of vitamin A and palmitic acid on human stem cell-derived hepatic stellate cells
15 (1), 223
DOI 10.1186/s13287-024-03852-8, PubMed 39044210

Publications 2023

Gjølberg TT, Wik JA, Johannessen H, Krüger S, Bassi N, Christopoulos PF, Bern M, Foss S, Petrovski G, Moe MC, Haraldsen G, Fosse JH, Skålhegg BS, Andersen JT, Sundlisæter E (2023)
Antibody blockade of Jagged1 attenuates choroidal neovascularization
14 (1), 3109
DOI 10.1038/s41467-023-38563-w, PubMed 37253747

Publications 2022

Wik JA, Chowdhury A, Kolan S, Bastani NE, Li G, Alam K, Grimolizzi F, Skålhegg BS (2022)
Endogenous glutamine is rate-limiting for anti-CD3 and anti-CD28 induced CD4+ T-cell proliferation and glycolytic activity under hypoxia and normoxia
479 (11), 1221-1235
DOI 10.1042/BCJ20220144, PubMed 35695514

Wik JA, Skålhegg BS (2022)
T Cell Metabolism in Infection
13, 840610
DOI 10.3389/fimmu.2022.840610, PubMed 35359994

Publications 2021

Cederkvist H, Kolan SS, Wik JA, Sener Z, Skålhegg BS (2021)
Identification and characterization of a novel glutaminase inhibitor
12 (1), 163-174
DOI 10.1002/2211-5463.13319, PubMed 34698439

Wik JA, Phung D, Kolan S, Haraldsen G, Skålhegg BS, Hol Fosse J (2021)
Inflammatory activation of endothelial cells increases glycolysis and oxygen consumption despite inhibiting cell proliferation
11 (6), 1719-1730
DOI 10.1002/2211-5463.13174, PubMed 33979025

Publications 2020

Kolan SS, Li G, Wik JA, Malachin G, Guo S, Kolan P, Skålhegg BS (2020)
Cellular metabolism dictates T cell effector function in health and disease
92 (5), e12956
DOI 10.1111/sji.12956, PubMed 32767795

Wik JA, Lundbäck P, la Cour Poulsen L, Haraldsen G, Skålhegg BS, Hol J (2020)
3PO inhibits inflammatory NFκB and stress-activated kinase signaling in primary human endothelial cells independently of its target PFKFB3
15 (3), e0229395
DOI 10.1371/journal.pone.0229395, PubMed 32130250